Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of bisphosphonates on skeletal response to mechanical stimulation in pediatric osteogenesis imperfecta
2016-003606-14Phase 2Completed
- Sponsor
- Sheffield Children's Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of risedronate in osteogenesis imperfecta (OI), sponsored by Sheffield Children's Hospital. Primary endpoint: Change in P1NP after mechanical stimulation following risedronate. Started Oct 2016; status: completed.
02
Drugs
risedronate
03
Conditions
osteogenesis imperfecta (OI)
Beyond the preview
Go deeper on 2016-003606-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003606-14.